Evidence for the importance of OxPAPC interaction with cysteines in regulating endothelial cell function

Journal of Lipid Research

Volumn 53, Issue 7, 2012, Pages 1304-1315

  Springstead, James R ^a   Gugiu, B Gabriel ^a   Lee, Sangderk ^a   Seung, Cha ^a   Watson, Andrew D ^a   Berliner, Judith A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Covalent binding; Endothelial cells; Gene regulation; Inflammation; Mass spectrometry; Microarray; Oxidative stress; Oxidized phospholipid

Indexed keywords

1 PALMITOYL 2 (5,6 EPOXYISOPROSTANE E2) SN GLYCERO 3 PHOSPHATIDYL (N BIOTINYLETHANOLAMINE); 1 PALMITOYL 2 (5,6) EPOXYISOPROSTANE E2 SN GLYCERO 3 PHOSPHATIDYLCHOLINE; 1 PALMITOYL 2 ARACHIDONOYL GLYCEROL 3 PHOSPHATIDYL (N BIOTINYLETHANOLAMINE); 1 PALMITOYL 2 ARACHIDONOYL GLYCEROL 3 PHOSPHATIDYLCHOLINE; 15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ACETYLCYSTEINE; CELL PROTEIN; CYSTEINE; HUMAN AORTIC ENDOTHELIAL CELL PROTEIN; N ETHYLMALEIMIDE; PHOSPHATIDYLCHOLINE; PROTEIN H RAS; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AORTA; ARTICLE; BINDING KINETICS; BIOTINYLATION; CELL FUNCTION; CONCENTRATION (PARAMETERS); ENDOTHELIUM CELL; GENE CONTROL; HUMAN; HUMAN CELL; INFLAMMATION; MASS SPECTROMETRY; MICROARRAY ANALYSIS; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM;

BINDING SITES; CELLS, CULTURED; CYSTEINE; ENDOTHELIAL CELLS; ETHYLMALEIMIDE; HUMANS; ISOPROSTANES; PHOSPHATIDYLCHOLINES; PROSTAGLANDIN D2;

EID: 84862327417     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M025320     Document Type: Article

References (47)

1. Berliner, J. A., M. Navab, A. M. Fogelman, J. S. Frank, L. L. Demer, P. A. Edwards, A. D. Watson, and A. J. Lusis. 1995. Atherosclerosis: basic mechanisms. oxidation, inflammation, and genetics. Circulation. 91: 2488-2496.
2. Berliner, J. A., N. Leitinger, and S. Tsimikas. 2009. The role of oxidized phospholipids in atherosclerosis. J. Lipid Res. 50 (Suppl): S207-S212.
3. Romanoski, C. E., N. Che, F. Yin, N. Mai, D. Pouldar, M. Civelek, C. Pan, S. Lee, L. Vakili, W. P. Yang, et al. 2011. Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1. Circ. Res. 109: e27-e41.
4. Gugiu, B. G., K. Mouillesseaux, V. Duong, T. Herzog, A. Hekimian, L. Koroniak, T. M. Vondriska, and A. D. Watson. 2008. Protein targets of oxidized phospholipids in endothelial cells. J. Lipid Res. 49: 510-520.
5. Gao, D., M. Z. Ashraf, N. S. Kar, D. Lin, L. M. Sayre, and E. A. Podrez. 2010. Structural basis for the recognition of oxidized phospholipids in oxidized low density lipoproteins by class B scavenger receptors CD36 and SR-BI. J. Biol. Chem. 285: 4447-4454.
6. Jung, M. E., J. A. Berliner, L. Koroniak, B. G. Gugiu, and A. D. Watson. 2008. Improved synthesis of the epoxy isoprostane phospholipid PEIPC and its reactivity with amines. Org. Lett. 10: 4207-4209.
7. Zimman, A., K. P. Mouillesseaux, T. Le, N. M. Gharavi, A. Ryvkin, T. G. Graeber, T. T. Chen, A. D. Watson, and J. A. Berliner. 2007. Vascular endothelial growth factor receptor 2 plays a role in the activation of aortic endothelial cells by oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 27: 332-338. (Pubitemid 46143048)
8. Birukov, K. G., N. Leitinger, V. N. Bochkov, and J. G. Garcia. 2004. Signal transduction pathways activated in human pulmonary endothelial cells by OxPAPC, a bioactive component of oxidized lipoproteins. Microvasc. Res. 67: 18-28. (Pubitemid 38050220)
9. Cole, A. L., G. Subbanagounder, S. Mukhopadhyay, J. A. Berliner, and D. K. Vora. 2003. Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway. Arterioscler. Thromb. Vasc. Biol. 23: 1384-1390. (Pubitemid 36994526)
10. Fu, P., and K. G. Birukov. 2009. Oxidized phospholipids in control of inflammation and endothelial barrier. Transl. Res. 153: 166-176.
11. Leitinger, N. 2005. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol. Nutr. Food Res. 49: 1063-1071. (Pubitemid 41735566)
12. Oliva, J. L., D. Perez-Sala, A. Castrillo, N. Martinez, F. J. Canada, L. Bosca, and J. M. Rojas. 2003. The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras. Proc. Natl. Acad. Sci. USA. 100: 4772-4777. (Pubitemid 36469241)
13. Roy, S., S. Plowman, B. Rotblat, I. A. Prior, C. Muncke, S. Grainger, R. G. Parton, Y. I. Henis, Y. Kloog, and J. F. Hancock. 2005. Individual palmitoyl residues serve distinct roles in H-ras trafficking, microlocalization, and signaling. Mol. Cell. Biol. 25: 6722-6733. (Pubitemid 41023244)
14. Renedo, M., J. Gayarre, C. A. Garcia-Dominguez, A. Perez-Rodriguez, A. Prieto, F. J. Canada, J. M. Rojas, and D. Perez-Sala. 2007. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. Biochemistry. 46: 6607-6616. (Pubitemid 46870126)
15. Oeste, C. L., B. Diez-Dacal, F. Bray, M. Garcia de Lacoba, B. G. de la Torre, D. Andreu, A. J. Ruiz-Sanchez, E. Perez-Inestrosa, C. A. Garcia-Dominguez, J. M. Rojas, et al. 2011. The C-terminus of H-Ras as a target for the covalent binding of reactive compounds modulating Ras-dependent pathways. PLoS ONE. 6: e15866.
16. Watson, A. D., G. Subbanagounder, D. S. Welsbie, K. F. Faull, M. Navab, M. E. Jung, A. M. Fogelman, and J. A. Berliner. 1999. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein. J. Biol. Chem. 274: 24787-24798.
17. Berliner, J. A., M. C. Territo, A. Sevanian, S. Ramin, J. A. Kim, B. Bamshad, M. Esterson, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85: 1260-1266. (Pubitemid 20123772)
18. Navab, M., S. S. Imes, S. Y. Hama, G. P. Hough, L. A. Ross, R. W. Bork, A. J. Valente, J. A. Berliner, D. C. Drinkwater, H. Laks, et al. 1991. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 88: 2039-2046.
19. Kawasaki, K., T. Watabe, H. Sase, M. Hirashima, H. Koide, Y. Morishita, K. Yuki, T. Sasaoka, T. Suda, M. Katsuki, et al. 2008. Ras signaling directs endothelial specification of VEGFR2+ vascular progenitor cells. J. Cell Biol. 181: 131-141. (Pubitemid 351519770)
20. Yamauchi, J., Y. Miyamoto, A. Tanoue, E. M. Shooter, and J. R. Chan. 2005. Ras activation of a Rac1 exchange factor, Tiam1, mediates neurotrophin-3-induced Schwann cell migration. Proc. Natl. Acad. Sci. USA. 102: 14889-14894. (Pubitemid 41457151)
21. Waku, T., T. Shiraki, T. Oyama, Y. Fujimoto, K. Maebara, N. Kamiya, H. Jingami, and K. Morikawa. 2009. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids. J. Mol. Biol. 385: 188-199.
22. Roy, M., Z. Li, and D. B. Sacks. 2005. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling. Mol. Cell. Biol. 25: 7940-7952. (Pubitemid 41262989)
23. Bell-Parikh, L. C., T. Ide, J. A. Lawson, P. McNamara, M. Reilly, and G. A. FitzGerald. 2003. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J. Clin. Invest. 112: 945-955.
24. Lee, H., W. Shi, P. Tontonoz, S. Wang, G. Subbanagounder, C. C. Hedrick, S. Hama, C. Borromeo, R. M. Evans, J. A. Berliner, et al. 2000. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ. Res. 87: 516-521.
25. Boyault, S., A. Bianchi, D. Moulin, S. Morin, M. Francois, P. Netter, B. Terlain, and K. Bordji. 2004. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway. FEBS Lett. 572: 33-40. (Pubitemid 39092509)
26. Kadl, A., A. K. Meher, P. R. Sharma, M. Y. Lee, A. C. Doran, S. R. Johnstone, M. R. Elliott, F. Gruber, J. Han, W. Chen, et al. 2010. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ. Res. 107: 737-746.
27. Li, R., W. Chen, R. Yanes, S. Lee, and J. A. Berliner. 2007. OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids. J. Lipid Res. 48: 709-715. (Pubitemid 46397474)
28. Gargalovic, P. S., N. M. Gharavi, M. J. Clark, J. Pagnon, W. P. Yang, A. He, A. Truong, T. Baruch-Oren, J. A. Berliner, T. G. Kirchgessner, et al. 2006. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26: 2490-2496. (Pubitemid 44607470)
29. Harrison, D., K. K. Griendling, U. Landmesser, B. Hornig, and H. Drexler. 2003. Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 91: 7A-11A. (Pubitemid 36351457)
30. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924. (Pubitemid 19101597)
31. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
32. Witztum, J. L. 1994. The oxidation hypothesis of atherosclerosis. Lancet. 344: 793-795. (Pubitemid 24283962)
33. Parthasarathy, S., and N. Santanam. 1994. Mechanisms of oxidation, antioxidants, and atherosclerosis. Curr. Opin. Lipidol. 5: 371-375. (Pubitemid 24341347)
34. Vogiatzi, G., D. Tousoulis, and C. Stefanadis. 2009. The role of oxidative stress in atherosclerosis. Hellenic J. Cardiol. 50: 402-409.
35. Stocker, R., and J. F. Keaney, Jr. 2005. New insights on oxidative stress in the artery wall. J. Thromb. Haemost. 3: 1825-1834. (Pubitemid 41716569)
36. Ross, A. C., and R. Zolfaghari. 2011. Cytochrome P450s in the regulation of cellular retinoic acid metabolism. Annu. Rev. Nutr. 31: 65-87.
37. Herdeg, C., M. Oberhoff, A. Baumbach, S. Schroeder, M. Leitritz, A. Blattner, D. I. Siegel-Axel, C. Meisner, and K. R. Karsch. 2003. Effects of local all-trans-retinoic acid delivery on experimental atherosclerosis in the rabbit carotid artery. Cardiovasc. Res. 57: 544-553. (Pubitemid 36144231)
38. Garcia-Ramirez, M., J. Martinez-Gonzalez, J. O. Juan-Babot, C. Rodriguez, and L. Badimon. 2005. Transcription factor SOX18 is expressed in human coronary atherosclerotic lesions and regulates DNA synthesis and vascular cell growth. Arterioscler. Thromb. Vasc. Biol. 25: 2398-2403. (Pubitemid 41552661)
39. Dulin, E., P. Garcia-Barreno, and M. C. Guisasola. 2010. Extracellular heat shock protein 70 (HSPA1A) and classical vascular risk factors in a general population. Cell Stress Chaperones. 15: 929-937.
40. Scher, J. U., and M. H. Pillinger. 2005. 15d-PGJ2: the anti-inflammatory prostaglandin? Clin. Immunol. 114: 100-109.
41. Bishop-Bailey, D., and T. Hla. 1999. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2. J. Biol. Chem. 274: 17042-17048.
42. Powell, W. S. 2003.\par 15-Deoxy-delta12,14-PGJ2: endogenous PPAR-gamma ligand or minor eicosanoid degradation product? J. Clin. Invest. 112: 828-830. (Pubitemid 38063740)
43. Garzón, B., C. L. Oeste, B. Diez-Dacal, and D. Perez-Sala. 2011. Proteomic studies on protein modification by cyclopentenone prostaglandins: expanding our view on electrophile actions. J. Proteomics. 74: 2243-2263.
44. Subbanagounder, G., N. Leitinger, D. C. Schwenke, J. W. Wong, H. Lee, C. Rizza, A. D. Watson, K. F. Faull, A. M. Fogelman, and J. A. Berliner. 2000. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arterioscler. Thromb. Vasc. Biol. 20: 2248-2254.
45. Podrez, E. A., T. V. Byzova, M. Febbraio, R. G. Salomon, Y. Ma, M. Valiyaveettil, E. Poliakov, M. Sun, P. J. Finton, B. R. Curtis, et al. 2007. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat. Med. 13: 1086-1095. (Pubitemid 47517507)
46. Oskolkova, O. V., T. Afonyushkin, B. Preinerstorfer, W. Bicker, E. von Schlieffen, E. Hainzl, S. Demyanets, G. Schabbauer, W. Lindner, A. D. Tselepis, et al. 2010. Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation. J. Immunol. 185: 7706-7712.
47. Weerapana, E., C. Wang, G. M. Simon, F. Richter, S. Khare, M. B. Dillon, D. A. Bachovchin, K. Mowen, D. Baker, and B. F. Cravatt. 2010. Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature. 468: 790-795.